Vivacell Biotechnology Espana S.L.

Peripheral Arterial Disease

Clinical research activity is centered on peripheral arterial disease, with attention to patients affected by impaired limb circulation and related vascular symptoms.

  • Leg circulation disorders
  • Vascular insufficiency
  • Peripheral ischemia

The sponsor’s trial portfolio reflects interest in therapeutic options for improving arterial blood flow in the lower extremities and addressing the clinical burden of chronic vascular disease.

Vascular Medicine

Research activity also falls within vascular medicine, focusing on conditions that affect the structure and function of peripheral arteries and the circulation to the limbs.

  • Peripheral arterial circulation
  • Chronic limb ischemia
  • Arterial occlusive disease

Interest in this area supports clinical development aimed at managing symptoms and disease progression in patients with peripheral vascular disease.

Cardiovascular Therapeutics

The sponsor’s work extends into cardiovascular therapeutics, with a specific emphasis on treatment strategies relevant to circulatory impairment in the peripheral vascular system.

  • Circulatory restoration
  • Ischemic limb conditions
  • Symptom control in PAD

This therapeutic focus aligns with efforts to evaluate new options for patients living with vascular-related mobility limitations and reduced limb perfusion.

Drug Development for Peripheral Vascular Disease

Clinical investigation includes drug development for peripheral vascular disease, with an emphasis on assessing treatment performance in a patient population with limited circulatory reserve.

  • Safety and tolerability
  • Preliminary efficacy
  • Long-term treatment use

The research interest is directed toward pharmacologic approaches intended for chronic management of peripheral arterial disease.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Etrinabdione for Patients with Peripheral Arterial Disease: Evaluating Safety and Tolerability

    Not recruiting

    2 1 1
    Investigated drugs:
    Spain